Cirrhosis and Pneumonia: How Liver Disease Affects Lung Defenses
Author Information
Author(s): Propst-Graham Katie L, Preheim Laurel C, Vander Top Elizabeth A, Snitily Mary U, Gentry-Nielsen Martha J
Primary Institution: Creighton University School of Medicine
Hypothesis
The severely cirrhotic host has increased mortality from pneumococcal pneumonia due to compromised innate defenses, and pneumolysin may also be especially detrimental to the cirrhotic rats during a respiratory tract infection.
Conclusion
Cirrhotic rats have significant impairments in both early and later pulmonary defenses against pneumococcal pneumonia, contributing to increased mortality.
Supporting Evidence
- Early intrapulmonary killing of pneumococci was significantly impaired in cirrhotic rats.
- Neutrophil-mediated killing of a virulent pneumococcal strain was significantly diminished in cirrhotic rats.
- Levels of lysozyme and complement C3 were significantly reduced in bronchoalveolar lavage fluid from cirrhotic rats.
- Complement deposition on pneumococci was reduced in cirrhotic rats compared to controls.
Takeaway
When people have liver disease, their lungs have a harder time fighting off pneumonia, which can make them sicker. A specific toxin from the bacteria makes this problem worse.
Methodology
The study used a cirrhotic rat model to assess pulmonary defenses against pneumococcal pneumonia, measuring mucociliary clearance, pre-neutrophil and neutrophil-mediated killing, and complement deposition.
Limitations
The study could not determine whether pneumolysin more negatively impacted defense mechanisms in cirrhotic than in control rats.
Participant Demographics
Outbred 200 gram male Sprague-Dawley rats were used in the study.
Statistical Information
P-Value
0.035
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website